Synthesis and Antimicrobial Activity of Some 5-[2-(Morpholin-4-yl)acetamido] and/or 5-[2-(4-Substituted piperazin-1-yl)acetamido]-2-(<i>p</i>-substituted phenyl)benzoxazoles
作者:Özlem Temiz-Arpacı、Aliye Özdemir、İsmail Yalçın、İlkay Yıldız、Esin Akı-Şener、Nurten Altanlar
DOI:10.1002/ardp.200400923
日期:2005.3
pip‐erazine‐1‐yl)acetamido]‐2‐(p‐substituted phenyl]benzoxazole derivatives have been synthesized and their structures were confirmed by IR, 1H NMR, and mass spectral data. These compounds were prepared by reacting 5‐(2‐chloroacetamido)‐2‐(4‐p‐substituted‐phenyl)benzoxazoles, which were obtained by using 5‐amino‐2‐[p‐substituted‐phenyl]benzoxazoles with chloroacetyl chloride, in the presence of morpholine
在本研究中,一系列 12 种新型 5-[2-(吗啉-4-基)乙酰氨基] 和/或 5-[2-(4-取代哌嗪-1-基)乙酰氨基]-2-(p -取代苯基]苯并恶唑衍生物已合成,其结构经红外、1H核磁共振和质谱数据证实。这些化合物是通过5-(2-氯乙酰胺)-2-(4-对-取代-苯基)反应制备的5-氨基-2-[p-取代-苯基]苯并恶唑与氯乙酰氯在吗啉或1-取代哌嗪的存在下得到苯并恶唑。所有合成的化合物3-14均采用双重方法测试与标准药物相比,针对某些革兰氏阳性菌、革兰氏阴性菌以及白色念珠菌、克柔念珠菌和光滑念珠菌的体外活性的连续稀释技术。微生物学结果表明,新合成的化合物具有广谱活性,对念珠菌菌种的MIC值为3.12-50 μg/mL。